Randy W. Schekman, professor of molecular and cell biology at the University of California, Berkeley, has won the 2013 Nobel Prize in Physiology or Medicine for his role in revealing the machinery that regulates the transport and secretion of proteins in our cells. He shares the prize with James E. Rothman of Yale University and Thomas C. Südhof of Stanford University.

Some 10 percent of the population suffers from eczema at some point in their lives. The chronic skin condition, for which there are no cures or good treatments, causes symptoms ranging from dry, flaky and itchy skin to flaming red rashes and, particularly in children, nasal allergies and asthma.

Researchers are using computer simulations to investigate how ultrasound and tiny bubbles injected into the bloodstream might break up blood clots, limiting the damage caused by a stroke in its first hours.

Computational Biologist Steven Brenner will be part of an ambitious effort to assess whether large-scale gene sequencing aimed at detecting disorders and conditions can and should become a routine part of newborn testing.

Knocking out a single enzyme dramatically cripples the ability of aggressive cancer cells to spread and grow tumors, offering a promising new target in the development of cancer treatments, according to a new study by researchers at the University of California, Berkeley.

Cocaine can speedily rewire high-level brain circuits that support learning, memory and decision-making, according to new research from UC Berkeley and UCSF. The findings shed new light on the frontal brain’s role in drug-seeking behavior and may be key to tackling addiction.

Engineers at the University of California, Berkeley, have built a device that could speed up medical imaging without breaking the bank. The key ingredient? An engine lubricant called molybdenum disulfide, or MoS2, which has been sold in auto parts shops for decades.

In the first study to evaluate the health risks of exposure to secondhand smoke for patrons of restaurants and bars, researchers have found that the risks are well above the acceptable level. The study assessed the risk for lung cancer and heart disease deaths among both patrons and servers and also for asthma initiation—the first study to do so—among servers.

A new milestone by engineers at UC Berkeley can help robots become more touchy-feely, literally.

Study at Berkeley Lab’s Advanced Light Source links vitamin D deficiency to accelerated aging of bones.

Evidence is mounting that the development and spread of cancer, long attributed to gene expression and chemical signaling gone awry, involves a biomechanical component as well.

Berkeley Lab scientists create atomic-scale structure of ribosome attached to a molecule that controls its motion

Researchers at UC Berkeley have developed an easier and more effective method for inserting genes into eye cells that could greatly expand gene therapy to help restore sight to patients with blinding diseases ranging from inherited defects like retinitis pigmentosa to degenerative illnesses of old age, such as macular degeneration.

New research by neuroscientists at UC Berkeley, suggests that the human brain is not detail-oriented, but opts for the big picture when it comes to hearing.

Five UC Berkeley scientists eager to take their lab-bench discoveries into the marketplace have been awarded Bakar Fellowships to help them achieve their goals.

Every chemist’s dream – to snap an atomic-scale picture of a chemical before and after it reacts – has now come true, thanks to a new technique developed by chemists and physicists at the University of California, Berkeley.

New technology developed at the University of California, Berkeley, is using wireless signals to provide real-time, non-invasive diagnoses of brain swelling or bleeding.

From brain to heart to stomach, the bodies of humans and animals generate weak magnetic fields that a supersensitive detector could use to pinpoint illnesses, trace drugs – and maybe even read minds. Sensors no bigger than a thumbnail could map gas deposits underground, analyze chemicals, and pinpoint explosives that hide from other probes.

Nicole King, Russell Vance and Michael Rape took different routes to UC Berkeley’s Department of Molecular and Cell Biology, but they’ve ended up with one of the mostly highly sought positions at any American university: a fully subsidized appointment, with added research funds, as a Howard Hughes Medical Institute (HHMI) investigator.

On April 25, World Malaria Day, the nonprofit Zagaya released a video Illustrating why, in the words of UC Berkeley synthetic biologist Jay Keasling, “it took a village” to create an accessible treatment for malaria that will be essential to eradicating the disease.

Twelve years after a breakthrough discovery in his University of California, Berkeley, laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true.

Michael Rape studies ubiqutins that form chains, “like pearls on a string,” he says. In 2008, his lab discovered a new member of this chain configuration and determined how an enzyme called Ube2S is able to assemble it inside cells. Without the Ube2S enzyme and the ubiquitin chain, he found, cells cannot divide. But with too much Ube2S – and too many ubiquitin chains – cell division runs out of control.

Three UC Berkeley scientists were among a gathering of the nation’s top scientists at the White House this morning (Tuesday, April 2) as President Barack Obama announced a major national initiative to develop new tools to create real-time traffic maps of the human brain.

Lab tests that detect prostate cancer can’t reveal if the cancer poses a real risk. It looks for elevated levels of a protein called PSA, but about 80 percent of cancers that generate high PSA levels grow so slowly and may never need treatment. New research by Amy Herr points the way to a much more refined assessment of proteins and the promise of better diagnosis and treatment of a range of diseases. 

Your cells are social butterflies. They constantly interact with their surroundings, taking in cues on when to divide and where to anchor themselves, among other critical tasks.

Researchers with Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley have provided important new details into the activation of the epidermal growth factor receptor (EGFR), a cell surface protein that has been strongly linked to a large number of cancers and is a major target of cancer therapies.

Dr. Michael Rape, Bakar Fellow and Associate Professor of Cell and Development and Biology at UC Berkeley, was awarded the Vilcek Prize for Creative Promise in Biomedical Science. He is a leading biochemical researcher helping to unravel the mysteries of the ubiquitin system, which tags damaged or bad proteins for destruction, and others for elimination to enable certain processes to occur, and therefore vital to the health of all life-forms.